Therefore, it is reasonable to assume that FTO regulates the stability of CD36 mRNA via YTHDF2 dependent on the m6A modification in hyperlipidemia and PA-induced cardiomyocyte inflammation. Here, CD36 is linked to hyperlipidemia.